Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1964 1
1965 1
1966 3
1967 4
1968 4
1969 8
1970 2
1971 3
1972 4
1973 6
1974 9
1975 4
1976 3
1977 1
1978 1
1979 3
1980 1
1981 6
1982 6
1983 3
1984 9
1985 4
1986 7
1987 7
1988 12
1989 9
1990 7
1991 10
1992 8
1993 9
1994 8
1995 15
1996 12
1997 10
1998 9
1999 9
2000 11
2001 14
2002 7
2003 11
2004 7
2005 16
2006 14
2007 4
2008 23
2009 10
2010 15
2011 23
2012 27
2013 24
2014 21
2015 20
2016 19
2017 21
2018 41
2019 22
2020 28
2021 29
2022 24
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

624 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin D: 100 years of discoveries, yet controversy continues.
Gallagher JC, Rosen CJ. Gallagher JC, et al. Lancet Diabetes Endocrinol. 2023 May;11(5):362-374. doi: 10.1016/S2213-8587(23)00060-8. Epub 2023 Mar 30. Lancet Diabetes Endocrinol. 2023. PMID: 37004709 Review.
Furthermore, recommended daily allowances for vitamin D have been established and large clinical trials of vitamin D, aimed at clarifying the effect of Vitamin D in the prevention of multiple diseases, have been completed. However, disappointingly, these clinical tr …
Furthermore, recommended daily allowances for vitamin D have been established and large clinical trials of vitamin D, aimed at clarif …
Rickets guidance: part II-management.
Haffner D, Leifheit-Nestler M, Grund A, Schnabel D. Haffner D, et al. Pediatr Nephrol. 2022 Oct;37(10):2289-2302. doi: 10.1007/s00467-022-05505-5. Epub 2022 Mar 29. Pediatr Nephrol. 2022. PMID: 35352187 Free PMC article.
Adjustment of medication should be done with consideration of treatment-associated side effects, including diarrhea, gastrointestinal discomfort, hypercalciuria, secondary hyperparathyroidism, and development of nephrocalcinosis or nephrolithiasis....
Adjustment of medication should be done with consideration of treatment-associated side effects, including diarrhea, gastrointestinal discom …
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ, Singh RJ, Kumar R. Tebben PJ, et al. Endocr Rev. 2016 Oct;37(5):521-547. doi: 10.1210/er.2016-1070. Epub 2016 Sep 2. Endocr Rev. 2016. PMID: 27588937 Free PMC article. Review.
Patients with biallelic and, in some instances, monoallelic mutations of the CYP24A1 gene have elevated serum calcium concentrations associated with elevated serum 1,25(OH)(2)D, suppressed PTH concentrations, hypercalciuria, nephrocalcinosis, nephrolithiasis, and on occasi …
Patients with biallelic and, in some instances, monoallelic mutations of the CYP24A1 gene have elevated serum calcium concentrations associa …
Hypocalcemia: updates in diagnosis and management for primary care.
Fong J, Khan A. Fong J, et al. Can Fam Physician. 2012 Feb;58(2):158-62. Can Fam Physician. 2012. PMID: 22439169 Free PMC article. Review.
Acute and life-threatening calcium deficit requires treatment with intravenous calcium.The current treatment recommendations are largely based on expert clinical opinion and published case reports,as adequately controlled clinical trial data are not currently …
Acute and life-threatening calcium deficit requires treatment with intravenous calcium.The current treatment recommendations are largely bas …
Hypophosphatemic Rickets.
Bitzan M, Goodyer PR. Bitzan M, et al. Pediatr Clin North Am. 2019 Feb;66(1):179-207. doi: 10.1016/j.pcl.2018.09.004. Pediatr Clin North Am. 2019. PMID: 30454743 Review.
Hypophosphatemic rickets, mostly of the X-linked dominant form caused by pathogenic variants of the PHEX gene, poses therapeutic challenges with consequences for growth and bone development and portends a high risk of fractions and poor bone healing, dental problems and nephrolit …
Hypophosphatemic rickets, mostly of the X-linked dominant form caused by pathogenic variants of the PHEX gene, poses therapeutic challenges …
Parathyroid Disorders.
Sell J, Ramirez S, Partin M. Sell J, et al. Am Fam Physician. 2022 Mar 1;105(3):289-298. Am Fam Physician. 2022. PMID: 35289573 Free article.
Indications for parathyroidectomy in primary hyperparathyroidism include presence of symptoms, age 50 years or younger, serum calcium level more than 1 mg per dL above the upper limit of normal, osteoporosis, creatinine clearance less than 60 mL per minute per 1.73 m2, nephrolith …
Indications for parathyroidectomy in primary hyperparathyroidism include presence of symptoms, age 50 years or younger, serum calcium level …
Primary hyperoxaluria.
Lorenzo V, Torres A, Salido E. Lorenzo V, et al. Nefrologia. 2014 May 21;34(3):398-412. doi: 10.3265/Nefrologia.pre2014.Jan.12335. Epub 2014 Apr 30. Nefrologia. 2014. PMID: 24798559 Free article. Review. English, Spanish.
Diagnosis is based on family history, the presence of urolithiasis and/or nephrocalcinosis, hyperoxaluria, oxalate deposits in tissue forming granulomas, molecular analysis of DNA and enzyme analysis if applicable. ...Pre-emptive liver transplantation, or simultaneous live …
Diagnosis is based on family history, the presence of urolithiasis and/or nephrocalcinosis, hyperoxaluria, oxalate deposits in tissue …
Nephrocalcinosis.
Alon US. Alon US. Curr Opin Pediatr. 1997 Apr;9(2):160-5. Curr Opin Pediatr. 1997. PMID: 9204244 Review.
The routine use of ultrasonography has resulted in an explosion in the number of conditions reported to be associated with nephrocalcinosis. It has also been increasingly recognized that urolithiasis and nephrocalcinosis can coexist in the same patient. ...Among the …
The routine use of ultrasonography has resulted in an explosion in the number of conditions reported to be associated with nephrocalcinos …
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Michael M, et al. Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14. Am J Kidney Dis. 2023. PMID: 35843439 Free article. Clinical Trial.
ILLUMINATE-C evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamics of lumasiran in patients with PH1 and advanced kidney disease. STUDY DESIGN: Phase 3, open-label, single-arm trial. SETTING & PARTICIPANTS: Multinational study; enrolled patients with P …
ILLUMINATE-C evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamics of lumasiran in patients with PH1 and advanced kidney di …
AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
Yang X, Liu H, Ye T, Duan C, Lv P, Wu X, Liu J, Jiang K, Lu H, Yang H, Xia D, Peng E, Chen Z, Tang K, Ye Z. Yang X, et al. Theranostics. 2020 Oct 25;10(26):12011-12025. doi: 10.7150/thno.51144. eCollection 2020. Theranostics. 2020. PMID: 33204326 Free PMC article.
Calcium oxalate (CaOx) crystal can trigger kidney injury, which contributes to the pathogenesis of nephrocalcinosis. The phenotypes of infiltrating macrophage may impact CaOx-mediated kidney inflammatory injury as well as crystal deposition. How aryl hydrocarbon receptor ( …
Calcium oxalate (CaOx) crystal can trigger kidney injury, which contributes to the pathogenesis of nephrocalcinosis. The phenotypes o …
624 results